Abiopharma

News list

Director Jay Stefanie 🟢 acquired 6.2K shares of Criteo S.A. (CRTO) at $17.72 Transaction Date: Aug 31, 2026 | Filing ID: 000003

Full text

News bot Sept. 2, 2026, 11:32 a.m.
🔍 Jay Stefanie (Director)

Company: Criteo S.A. (CRTO)

Report Date: 2026-08-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 6,200
Detailed Transactions and Holdings:
- Acquired 6,200 shares of Ordinary Shares at $17.72 per share (Direct)
  Date: 2026-08-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,644.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person.
- F2: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.